Abstract: According to one embodiment, a radioactive ray detecting apparatus includes: a scintillator that produces visible light from a radioactive ray; a light detecting portion including a light receiving element that generates an electrical signal on a basis of intensity of visible light; a first board; a first electrical connection unit that electrically connects the light detecting portion and a first surface of the first board to each other; a second board disposed to face the first board; a second electrical connection that electrically connects a first surface of the second board and a second surface of the first board being opposite from the first surface of the first board to each other; and a data acquisition device that processes an electrical signal transmitted from the light detecting portion through the first electrical connection unit, the first board, the second electrical connection unit, and the second board.

Abstract: An X-ray CT apparatus has an X-ray source, an X-ray detector, a temperature sensor, a data acquisition unit and a controller. The X-ray source generates an X-ray. The X-ray detector detects the X-ray. The temperature sensor detects a temperature of the X-ray detector. The data acquisition unit acquires data from the X-ray detector. The controller controls a temperature of the X-ray detector through adjustment of a workload of the data acquisition unit during a non-scanning time.

Abstract: Sulfoquinovosylacyl propanediol compounds represented by formula (I): wherein R1 is an acyl residue of a fatty acid, Y is a number of 1, 2 or 3, and M represents a cation having a positive charge equal to Y and pharmaceutically acceptable salts thereof are effective for treating tumors.

Abstract: An eyepiece lens system for an electronic viewfinder, usable to be disposed on an optical axis between a reflective LCD of the viewfinder and a last optical surface of the viewfinder, the eyepiece lens system comprising: a first lens having a positive refractive index; a second lens having a negative refractive index; and a third lens having a positive refractive index, wherein the first lens, the second lens, and the third lens are disposed in this order from a side of the LCD to a side of the last optical surface, satisfying the conditions: 18 mm<f1<20 mm, ?18 mm<f2<?16 mm, 18 mm<f3<20 mm, 19 mm<f<21 mm, and 0?HH?/f<+0.13 where f1 is a focal length of the first lens, f2 is a focal length of the second lens, f3 is a focal length of the third lens, f is a combined focal length of the first to the third lenses, and HH? is distance in an optical axis direction between a rear principal point H and a front principal point H?.

Abstract: A luggage support hook is attached to a center tunnel immediately above a storage unit, which is provided at a rear portion of a leg shield of a saddle-type vehicle, in order to provide a degree of freedom in a manner of hooking a hanging strap of an article to be hung on the luggage support hook, and to retain luggage in a stable state during travel. The luggage support hook is formed in a substantially Y-shape, when viewed from a front side, by a base member attached to a recess portion, a plurality of first arms projecting radially from a rear end of the base member, and a second arm member projecting from a position of the rear end of the base member. The second arm member is different from the first arms.

Abstract: Sulfoquinovosylacyl propanediol compounds represented by formula (I): wherein R1 is an acyl residue of a fatty acid, Y is a number of 1, 2 or 3, and M represents a cation having a positive charge equal to Y and pharmaceutically acceptable salts thereof are effective for treating tumors.

Abstract: An eyepiece lens system for an electronic viewfinder, usable to be disposed on an optical axis between a reflective LCD of the viewfinder and a last optical surface of the viewfinder, the eyepiece lens system comprising: a first lens having a positive refractive index; a second lens having a negative refractive index; and a third lens having a positive refractive index, wherein the first lens, the second lens, and the third lens are disposed in this order from a side of the LCD to a side of the last optical surface, satisfying the conditions: 18 mm<f1<20 mm, ?18 mm<f2<?16 mm, 18 mm<f3<20 mm, 19 mm<f<21 mm, and 0?HH?/f<+0.13 where f1 is a focal length of the first lens, f2 is a focal length of the second lens, f3 is a focal length of the third lens, f is a combined focal length of the first to the third lenses, and HH? is distance in an optical axis direction between a rear principal point H and a front principal point H?.

Abstract: A radiosensitizer comprising, as an active ingredient, at least one kind of compound selected from the group consisting of a compound represented by the following general formula (1): (wherein R101 represents an acyl residue of higher fatty acid, and R102 represents a hydrogen atom or an acyl residue of higher fatty acid), and a pharmaceutically acceptable salt thereof.

Abstract: Sulfoquinovosylacyl propanediol compounds represented by formula (I): wherein R1 is an acyl residue of a fatty acid, Y is a number of 1, 2 or 3, and M represents a cation having a positive charge equal to Y and pharmaceutically acceptable salts thereof are effective for treating tumors.

Abstract: A method for treating an adenocarcinoma excluding colon cancer, lung cancer and gastric cancer, comprising administering to a subject in need thereof and suffering from adenocarcinoma cancer, a pharmaceutically effective amount of at least one sulfoquinovosylacylglycerol compound represented by formula (1): wherein R101 represents an acyl residue of an unsaturated higher fatty acid, and R102 represents a hydrogen atom, and/or at least one pharmaceutically acceptable salt thereof.

Abstract: A radiosensitizer comprising, as an active ingredient, at least one kind of compound selected from the group consisting of a compound represented by the following general formula (1): (wherein R101 represents an acyl residue of higher fatty acid, and R102 represents a hydrogen atom or an acyl residue of higher fatty acid), and a pharmaceutically acceptable salt thereof.

Abstract: Peptides having, as constitutive amino acids, (1) 4 glutamine residues, 1 glutamic acid residue, 1 serine residue, 2 valine residues, 1 isoleucine residue and 5 leucine residues, and having a 3-hydroxydecanoyl group bonded, via an amide linkage, to the N-terminal leucine residue thereof; (2) 4 glutamine residues, 1 glutamic acid residue, 1 serine residue, 3 valine residues, and 5 leucine residues, and having a 3-hydroxydecanoyl group bonded, via an amide linkage, to the N-terminal leucine residue thereof; or (3) 4 glutamine residues, 1 glutamic acid residue, 1 serine residue, 2 valine residues, 1 isoleucine residue and 5 leucine residues, and having a 3-hydroxydodec-5-enoyl group bonded, via an amide linkage, to the N-terminal leucine residue thereof. The peptides have an antiviral activity. A strain capable of producing the above peptides and belonging to a new species of genus Pseudomonas.

Abstract: A semiconductor device manufacture method includes the steps of forming a resist layer above a work target layer; exposing and developing the resist layer to form resist patterns including isolated pattern and dense patterns; monitoring widths of isolated and dense pattern of the resist patterns to determine trimming amounts of linewidths to be reduced; determining etching conditions for realizing the trimming amounts of both the isolated and dense patterns, the etching conditions using mixed gas of a gas having a function of mainly enhancing etching and a gas having a function of mainly suppressing etching; trimming the resist pattern under said determined etching conditions; and etching the work target layer by using said trimmed resist patterns. A desired pattern width an be realized stably by trimming using plasma etching.

Abstract: A method for treating a cancer. The cancer excluding an adenocarcinoma and being epithelioma, glioma, sarcoma, melanoma, lymphoma or leukemia; or the cancer is an adenocarcinoma cancer excluding colon cancer, lung cancer and gastric cancer. The method comprises administering to a subject in need thereof and suffering from cancer, a pharmaceutically effective amount of at least one sulfoquinovosylacylglycerol compound represented by formula (1): wherein R101 represents an acyl residue of an unsaturated fatty acid and R102 represents a hydrogen atom and/or at least one pharmaceutically acceptable salt thereof.

Abstract: A method for treating an adenocarcinoma excluding colon cancer, lung cancer and gastric cancer, comprising administering to a subject in need thereof and suffering from adenocarcinoma cancer, a pharmaceutically effective amount of at least one sulfoquinovosylacylglycerol compound represented by formula (1): wherein R101 represents an acyl residue of an unsaturated higher fatty acid, and R102 represents a hydrogen atom, and/or at least one pharmaceutically acceptable salt thereof.

Abstract: An air conditioner is provided that includes an exhaust heat recovery unit for recovering exhaust heat in a heat transfer medium, a heat transfer medium passage in which the heat transfer medium outputted from the exhaust heat recovery unit flows, an auxiliary heating device, heats the heat transfer medium, an absorption chiller driven by heat of the heat transfer medium, a refrigerant passage, through which a refrigerant outputted from the absorption chiller flows, an indoor unit to which the refrigerant is supplied through the refrigerant passage, a heat transfer medium temperature detector for detecting the temperature of the heat transfer medium flowing through the heat transfer medium passage, a refrigerant temperature detector for detecting the temperature of the refrigerant flowing through the refrigerant passage, and a control portion for controlling an operation of driving the auxiliary heating device.

Abstract: A method for manufacturing a polyimide sleeve where a polyimide sleeve of a high quality can be manufactured easily with a superior yield. A sleeve of a release resin is fitted on a planished metal core or a core at least whose outer surface is made of a release resin, and a polyimide precursor solution is applied on its outer surface. Next, after generating an imide reaction of the polyimide precursor by heating to form an almost completely cured polyimide sleeve, this polyimide sleeve is removed from the core together with the sleeve of the release resin. Furthermore, the polyimide sleeve is separated from the sleeve of the release resin.

Abstract: There is constructed a constitution including an exhaust gas fired regenerator constituting a heat source by exhaust gas from an external machine generating the exhaust gas, an introducing flow path for guiding the exhaust gas to the exhaust gas fired regenerator, an exhaust flow path for exhausting the exhaust gas from the exhaust gas fired regenerator, a bypass flow path branched from the introducing flow path, flow path switching device including a first damper provided at the introducing flow path and a second damper provided at the bypass flow path for switching flow of the exhaust gas to the introducing flow path and the bypass flow path, a damper provided at the exhaust flow path for cutting off the exhaust gas from flowing in the exhaust flow path and gas delivering device for blowing a gas to a portion of the exhaust flow path between the damper for cutting off the exhaust gas from flowing and the exhaust gas fired regenerator.

Abstract: An immunosuppressive agent comprising, as an effective ingredient, at least one compound selected from the group consisting of compounds represented by general formula (1) below and pharmaceutically acceptable salts thereof: wherein R101 represents an acyl residue of a higher fatty acid, and R102 represents a hydrogen atom or acyl residue of a higher fatty acid.